Hepatitis Monthly

Published by: Kowsar

Occult Hepatitis C Virus Infection in Patients With Autoimmune Hepatitis

Mohammad Saeid Rezaee Zavareh 1 , 2 , Seyed Moayed Alavian 2 , * , Hamidreza Karimisari 1 , Mostafa Shafiei 2 and Seyed Yasser Saiedi Hosseini 2
Authors Information
1 Students' Research Committee, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
2 Middle East Liver Diseases Center (MELD), Tehran, IR Iran
Article information
  • Hepatitis Monthly: August 01, 2014, 14 (8); e16089
  • Published Online: August 10, 2014
  • Article Type: Brief Report
  • Received: November 10, 2013
  • Revised: December 27, 2013
  • Accepted: February 24, 2014
  • DOI: 10.5812/hepatmon.16089

To Cite: Rezaee Zavareh M S, Alavian S M, Karimisari H, Shafiei M, Saiedi Hosseini S Y. Occult Hepatitis C Virus Infection in Patients With Autoimmune Hepatitis, Hepat Mon. 2014 ; 14(8):e16089. doi: 10.5812/hepatmon.16089.

Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Madjd Z, Toosi MN, et al. Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease. J Med Virol. 2011; 83(6): 989-95[DOI][PubMed]
  • 2. Castillo I, Pardo M, Bartolome J, Ortiz-Movilla N, Rodriguez-Inigo E, de Lucas S, et al. Occult hepatitis C virus infection in patients in whom the etiology of persistently abnormal results of liver-function tests is unknown. J Infect Dis. 2004; 189(1): 7-14[DOI][PubMed]
  • 3. Castillo I, Bartolome J, Quiroga JA, Barril G, Carreno V. Diagnosis of occult hepatitis C without the need for a liver biopsy. J Med Virol. 2010; 82(9): 1554-9[DOI][PubMed]
  • 4. Carreno Garcia V, Nebreda JB, Aguilar IC, Quiroga Estevez JA. [Occult hepatitis C virus infection]. Enferm Infecc Microbiol Clin. 2011; 29 Suppl 3: 14-9[DOI][PubMed]
  • 5. Carreno V, Bartolome J, Castillo I, Quiroga JA. New perspectives in occult hepatitis C virus infection. World J Gastroenterol. 2012; 18(23): 2887-94[DOI][PubMed]
  • 6. Jadali Z, Alavian SM. Autoimmune diseases co-existing with hepatitis C virus infection. Iran J Allergy Asthma Immunol. 2010; 9(4): 191-206[PubMed]
  • 7. Krawitt EL. Autoimmune hepatitis. N Engl J Med. 2006; 354(1): 54-66[DOI][PubMed]
  • 8. Gossard AA, Lindor KD. Autoimmune hepatitis: a review. J Gastroenterol. 2012; 47(5): 498-503[DOI][PubMed]
  • 9. Bai L, Feng ZR, Lu HY, Li WG, Yu M, Xu XY. Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China. Chin Med J (Engl). 2009; 122(1): 5-9[PubMed]
  • 10. Cassani F, Cataleta M, Valentini P, Muratori P, Giostra F, Francesconi R, et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology. 1997; 26(3): 561-6[DOI][PubMed]
  • 11. Pavic S, Simonovic J, Boricic I, Svirtlih N. [Autoantibodies characteristic for autoimmune hepatitis found in chronic hepatitis C]. Srp Arh Celok Lek. 2003; 131(11-12): 437-42[PubMed]
  • 12. Vispo E, Maida I, Moreno A, Barreiro P, Soriano V. Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C. J Antimicrob Chemother. 2008; 62(6): 1470-2[DOI][PubMed]
  • 13. Kammer AR, van der Burg SH, Grabscheid B, Hunziker IP, Kwappenberg KM, Reichen J, et al. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition. J Exp Med. 1999; 190(2): 169-76[PubMed]
  • 14. Michitaka K, Durazzo M, Tillmann HL, Walker D, Philipp T, Manns MP. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2. Gastroenterology. 1994; 106(6): 1603-10[PubMed]
  • 15. Heintges T, Niederau C. Differentiation between autoimmune hepatitis and hepatitis C virus related liver disease. Z Gastroenterol. 1993; 31(5): 285-8[PubMed]
  • 16. Conrad B. Potential mechanisms of interferon-alpha induced autoimmunity. Autoimmunity. 2003; 36(8): 519-23[PubMed]
  • 17. Oeda S, Mizuta T, Isoda H, Kuwashiro T, Oza N, Iwane S, et al. Efficacy of pegylated interferon plus ribavirin in combination with corticosteroid for two cases of combined hepatitis C and autoimmune hepatitis. Clin J Gastroenterol. 2012; 5(2): 141-5[DOI][PubMed]
  • 18. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol. 1999; 31(5): 929-38[PubMed]
  • 19. Shafiei M, Alavian SM. Autoimmune hepatitis in Iran: what we know, what we don't know and requirements for better management. Hepat Mon. 2012; 12(2): 73-6[DOI][PubMed]
  • 20. Georgiadou SP, Zachou K, Liaskos C, Gabeta S, Rigopoulou EI, Dalekos GN. Occult hepatitis B virus infection in patients with autoimmune liver diseases. Liver Int. 2009; 29(3): 434-42[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments